Anne Caignard
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Editorial: New insights into innate immune cell-based immunotherapies in cancer.
Journal: Frontiers in immunology
Published: March 15, 2024
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Journal: Nature communications
Published: November 19, 2021
BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.
Journal: Journal for immunotherapy of cancer
Published: July 14, 2020
Two-dimensional dynamic evaluation of natural killer cell-mediated lysis of adherent target cells.
Journal: Methods in enzymology
Published: January 18, 2020
T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 30, 2019
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.
Journal: Frontiers in immunology
Published: December 07, 2018
Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.
Journal: Oncoimmunology
Published: April 27, 2018
CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes.
Journal: Cancer immunology research
Published: February 14, 2018
TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.
Journal: Oncoimmunology
Published: June 20, 2017
Last Updated: 09/26/2026